Actuated Medical Appoints Neurotechnology Leader JoJo Platt to Medical and Commercial Advisory Board. Accomplished neurotechnology strategist and ecosystem builder joins[...]

[Bellefonte, PA] - Actuated Medical, Inc., a clinical-stage medical device company focused on developing innovative technologies that improve patient care, today announced the appointment of JoJo Platt to its Medical and Commercial Advisory Board.

Platt's appointment further expands Actuated Medical's growing advisory board as the company advances commercialization of its NeuralGlider® precision brain access and therapy delivery platform and prepares for the next stage of growth within the neurotechnology sector.

"JoJo is one of the most respected and connected leaders in neurotechnology," said Maureen L. Mulvihill, Ph.D., President & CEO of Actuated Medical. "She brings a rare combination of industry knowledge, investor relationships, commercialization expertise, and strategic insight. As we continue to expand NeuralGlider's opportunities across deep brain stimulation, gene therapy delivery, neuro-oncology, and emerging neuroscience applications, her guidance will be invaluable."

Throughout her career, Platt has served as a catalyst within the neurotechnology community, helping connect entrepreneurs, researchers, investors, clinicians, and strategic partners to accelerate the development and adoption of innovative neurological therapies. Her leadership has spanned neurotechnology business development, commercialization strategy, ecosystem building, startup mentoring, and investor engagement.

In addition to leading Platt & Associates, she has held leadership roles supporting emerging neurotechnology companies and industry initiatives and has become a widely recognized advocate for advancing the field of neurotechnology.

"What excites me most about Actuated Medical is the team's ability to turn innovative ideas into real medical products that improve patient care," said JoJo Platt. "I am honored to join the Advisory Board and help accelerate the company's growth within the neurotechnology community."

Platt joins a distinguished advisory board that includes Dr. Chengyuan Wu, a leading functional neurosurgeon and deep brain stimulation specialist and Dr. Oguz Cataltepe, a nationally recognized pediatric neurosurgeon and innovator in image-guided neurosurgery. Together, the board provides Actuated Medical with world-class expertise spanning functional neurosurgery, brain access technologies, deep brain therapies, clinical translation, and neurotechnology commercialization.

"Actuated Medical has built a strong reputation for innovation, execution, and clinical impact," added Mulvihill. "By adding leaders like JoJo, we are expanding our expertise beyond clinical guidance to include commercialization, strategic partnerships, and investor engagement. That combination will be critical as we work to enable the future of neuroscience."

###

About Actuated Medical, Inc.

Actuated Medical, Inc. is a clinical-stage medical device company headquartered in Bellefonte, Pennsylvania, developing innovative motion-based technologies to solve challenging clinical problems. The company operates from a 20,000-square-foot facility, is ISO 13485 certified and FDA registered, and has built a portfolio that includes 43 U.S. and international patents and 9 FDA 510(k) clearances. Actuated Medical is advancing NeuralGlider® as a precision brain access and deep brain therapy delivery platform designed to support next-generation applications in gene therapy delivery, neuromodulation, brain-computer interfaces, and other emerging neurotechnology markets.

###

For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at [email protected].